← FDA DRUG APPROVALS

FDA ANDA · ANDA070225

VERAPAMIL HYDROCHLORIDE

Sponsor: LUITPOLD

APPLICATION
ANDA070225
TYPE
ANDA
ORIGINAL APPROVAL
1985-11-12
LATEST ACTION
1997-02-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

VERAPAMIL HYDROCHLORIDEDiscontinued
VERAPAMIL HYDROCHLORIDE 2.5MG/ML · INJECTABLE · INJECTION

Approval history

1997-02-27Manufacturing (CMC) · Supplement 14AP
1997-02-27Manufacturing (CMC) · Supplement 13AP
1995-12-13Labeling · Supplement 12AP
1993-05-28Manufacturing (CMC) · Supplement 7AP
1992-05-21Labeling · Supplement 11AP
1990-11-20Manufacturing (CMC) · Supplement 8AP
1990-11-20Manufacturing (CMC) · Supplement 6AP
1990-11-20Manufacturing (CMC) · Supplement 10AP
1990-11-20Manufacturing (CMC) · Supplement 9AP
1988-10-13Labeling · Supplement 5AP
1986-03-21Manufacturing (CMC) · Supplement 2AP
1986-03-21Manufacturing (CMC) · Supplement 1AP
1985-11-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →